Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health, under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto:
Schedule
Product: Betaloc CR
Active Ingredient(s): Metoprolol succinate 190mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Product: Betaloc CR
Active Ingredient(s): Metoprolol succinate 47.5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Product: Betaloc CR
Active Ingredient(s): Metoprolol succinate 95mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Dated this 25th day of January 2001.
GILLIAN GREW, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the
20th day of February 1997).